Functional analysis of pancreatic cancer-specific antigen highly expressed throughout the disease stage
Project/Area Number |
24591007
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | The University of Tokyo |
Principal Investigator |
IJICHI Hideaki 東京大学, 医学部附属病院, 講師 (70463841)
|
Co-Investigator(Kenkyū-buntansha) |
ISAYAMA Hiroyuki 東京大学, 医学部附属病院, 准教授 (70376458)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 膵癌 / PSCA / PSCA |
Outline of Final Research Achievements |
Prostate stem cell antigen (PSCA) is highly expressed throughout the early and advanced stage of pancreatic cancer (PCa) development. This suggests that PSCA might be assciated with the essential mechanism of cancer initiation and progression. PSCA can also be useful for molecular targeting therapy and early diagnosis. Our genetically-engineered mouse PCa model (Kras activation and TGF-beta receptor II knockout) demonstrated significant upregulation of PSCA in the cancer cells compared to precancer cells. PSCA knockdown in human PCa cells dramatically inhibited cell proliferation with marked apoptosis, which suggested functional importance of PSCA. However, the relation of PSCA function and intracellular signalings including TGF-beta-SMAD pathway remained unclear. Detailed function of PSCA and the underlying mechanism should be further investigated.
|
Report
(4 results)
Research Products
(2 results)